GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (OSTO:HNSA) » Definitions » Forward Dividend Yield %

Hansa Biopharma AB (OSTO:HNSA) Forward Dividend Yield % : 0.00% (As of Jun. 05, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hansa Biopharma AB Forward Dividend Yield %?

As of today (2024-06-05), the Forward Annual Dividend Yield of Hansa Biopharma AB is 0.00%.

As of today (2024-06-05), the Trailing Annual Dividend Yield of Hansa Biopharma AB is 0.00%.

OSTO:HNSA's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.665
* Ranked among companies with meaningful Forward Dividend Yield % only.

Hansa Biopharma AB's Dividends per Share for the three months ended in Mar. 2024 was kr0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Hansa Biopharma AB's Forward Dividend Yield %

For the Biotechnology subindustry, Hansa Biopharma AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansa Biopharma AB's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hansa Biopharma AB's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Hansa Biopharma AB's Forward Dividend Yield % falls into.



Hansa Biopharma AB Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Hansa Biopharma AB  (OSTO:HNSA) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Hansa Biopharma AB Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansa Biopharma AB (OSTO:HNSA) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB (OSTO:HNSA) Headlines

No Headlines